Featured News

IntelyCare today announced a $10.8 million investment to expand development and adoption of its intelligent workforce management solution for post-acute healthcare facilities.

09.20.18

Providence Medical Technology, Inc., an innovator in tissue-sparing surgical equipment and implants for cervical spine fusion surgery, today announced the closing of $25 million in new equity financing.

07.30.18

Liquidia Technologies Announces Closing of Initial Public Offering

 Liquidia Technologies, Inc. (the “Company”), a late-stage clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT® technology to transform the lives of patients, today announced the closing of its initial public offering...

The U.S. Food and Drug Administration today approved a new device, the Zephyr Endobronchial Valve (Zephyr Valve), intended to treat breathing difficulty associated with severe emphysema.

06.12.18

Leerink Revelation Partners Closes Second Fund at Hard Cap of $227 Million

Leerink Revelation Partners (LRP), an investment partnership formed in 2015 between Leerink Capital Partners and Revelation Partners to provide capital and liquidity solutions to healthcare investors, funds, founders and companies, announced the closing of a second fund...

06.28.18

Neuronetics prices $94m IPO

Neuronetics today priced its upcoming initial public offering, expecting to raise approximately $93.5 million to support its NeuroStar transcranial magnetic stimulation system designed to treat patients with major depressive disorder who aren’t responding to medication.

05.23.18

Three Arch's shares of AcelRx common stock acquired in a private transaction led by Leerink Revelation Partners and Industry Ventures

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx or the Company), a specialty pharmaceutical company focused on innovative therapies for use in medically supervised settings, today announced that all of AcelRx shares...